Skip to main content Skip to footer
Memorial Sloan Kettering Cancer Center

Sloan Kettering Institute

  • MSKCC.org Home
  • Find a Researcher
  • Contact Us
What can we help you find today?
  • About Us
  • Research
  • Education & Training
  • News & Events
  • Open Positions
    • MSKCC.org Home
    • Find a Researcher
    • Contact Us
  • Sloan Kettering Institute

Search

Search
Filter Results
  • All
  • Diseases (943)
  • Doctors (2494)
  • Labs (174)
  • Locations (80)
  • News (2853)
  • patient_resources (18244)
Language
for DoctorsXClear filters
Show 2494 results
Displaying 1381–1390 of 2494 results.
DoctorsXReset
Clinical Chemist
Hans G. Lilja

I am an attending research clinical chemist in the Departments of Laboratory Medicine, Surgery (Urology Service), and Medicine (Genitourinary Oncology Service) at Memorial Sloan Kettering Cancer Center. With my discovery of free PSA and other prostate-related proteins, I am primarily interested in circulating tumor markers that predict the development and progression of prostate cancer, as well as the possibility that these related markers play a key role in the pathogenesis of prostate cancer. I have contributed to over 180 peer-reviewed scientific publications, primarily detailing the relationship of biomarker proteins, prostate physiology, and pathology. I was a tenured professor at Lund University in Sweden until I moved to Memorial Sloan Kettering Cancer Center, and I still maintain an active relationship with my former laboratory at Lund University.

Clinical Chemist
Hans G. Lilja

Soy químico clínico investigador adjunto en los Departamentos de Medicina de Laboratorio, Cirugía (Servicio de Urología) y Medicina (Servicio de Oncología Genitourinaria) del Memorial Sloan Kettering Cancer Center. Gracias a mi descubrimiento del PSA libre y otras proteínas relacionadas con la próstata, principalmente, me interesan los marcadores tumorales circulantes que predicen el desarrollo y el avance del cáncer de próstata, así como la posibilidad de que estos marcadores relacionados actúen de forma clave en la patogénesis del cáncer de próstata. He contribuido en más de 180 publicaciones científicas revisadas por pares, en las que se detalla principalmente la relación entre las proteínas de biomarcadores, la fisiología de la próstata y la patología. Fui profesor titular en la Lund University en Suecia hasta que me trasladé al Memorial Sloan Kettering Cancer Center. Aún conservo una relación activa con mi antiguo laboratorio en la Lund University.

Pathologist
Rugved Pattarkine
Pathologist
Rugved Pattarkine
Behavioral Scientist
William Rosa
Behavioral Scientist
William Rosa
Dermatologist
Shamir Geller

I am a dermatologist who specializes in caring for patients with cutaneous (skin) lymphoma. I also have expertise in the diagnosis and treatment of basal cell carcinoma, squamous cell carcinoma, and early-stage melanoma, as well as other rare forms of skin cancer.

Dermatologist
Shamir Geller

Soy dermatólogo especializado en el cuidado de pacientes con linfoma cutáneo (de la piel). También tengo experiencia en el diagnóstico y tratamiento del carcinoma de células basales, el carcinoma de células escamosas y el melanoma en fase inicial, así como otras formas raras del cáncer de piel.

Bone Marrow Transplant Specialist
Miguel-Angel Perales

I am a board-certified medical oncologist with expertise in donor-derived hematopoietic (blood-forming) stem cell transplantation. Hematopoietic stem cells from a donor other than the patient can cure many patients who have diseases of the blood and bone marrow, including leukemias and lymphomas. The donor stem cells can come from different sources (related or unrelated donors, and bone marrow, peripheral blood, or umbilical cord blood units) and can be modified in different ways before transplantation to enhance their effectiveness.

Bone Marrow Transplant Specialist
Miguel-Angel Perales

Soy oncólogo médico certificado por la junta con experiencia en trasplantes de células madre hematopoyéticas (formadoras de sangre) derivadas de donantes. Las células madre hematopoyéticas de un donante distinto del paciente pueden curar a muchos pacientes que padecen enfermedades de la sangre y de la médula ósea, incluidas leucemias y linfomas. Las células madre del donante pueden provenir de diferentes fuentes (donantes emparentados o no y unidades de médula ósea, sangre periférica o sangre de cordón umbilical) y pueden modificarse de diferentes maneras antes del trasplante para mejorar su eficacia.

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 135
  • Page 136
  • Page 137
  • Page 138
  • Current page 139
  • Page 140
  • Page 141
  • Page 142
  • Page 143
  • …
  • Next page ››
  • Last page Last »
  • About Us
    • Overview
    • Leadership
    • Administration
    • History
    • Contact Us
      • Instagram
      • Facebook
      • X
      • YouTube
      • Linkedin
  • Research
    • Overview
    • Research programs
    • Research labs
    • Core facilities & resources
  • Education & Training
    • Overview
    • Postdoctoral training
    • Gerstner Sloan Kettering Graduate School
    • Joint graduate programs
    • Programs for college & high school students
  • News & Events
    • Overview
    • Seminars & events
  • Open Positions
    • Overview
    • Faculty positions
    • Postdoctoral positions
Memorial Sloan Kettering Cancer Center
  • Communication preferences
  • Cookie preferences
  • Legal disclaimer
  • Accessibility Statement
  • Privacy policy
  • Public notices
© 2026 Memorial Sloan Kettering Cancer Center
  • Log in drupal-666dc9945c-8jmlg